Natixis »

Soleno Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Soleno Therapeutics shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-03-31 $23k 692 33.48
2025-12-31 $641k 14k 46.30

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Energy Transfer Com Ut Ltd Ptn (ET)
Amazon (AMZN)
eBay (EBAY)

View all positions for Natixis

Top funds holding Soleno Therapeutics

Henderson Group
FMR
Wellington Management Company
BlackRock
State Street Corporation
Nantahala Capital Management
venBio Select Advisor
Vanguard Capital Management
Polar Capital Holdings
Caption Management
Susquehanna International
Khrom Capital Management
Geode Capital Management
Woodline Partners
Deep Track Capital

View all funds holding Soleno Therapeutics